Efficacy of abatacept or infliximab treatment in rheumatoid arthritis patients with an inadequate response to methotrexate: Results from a 1-year double-blind, randomized, placebo-controlled trial

被引：0
|
作者：
Bessette, L. [1 ]
Homik, J. [2 ]
Dougados, M. [3 ]
Keiserman, M. [4 ]
Codding, C. [5 ]
Songcharoen, S.
Berman, A. [6 ]
Nayiager, S. [7 ]
Saldate, C. [8 ]
Aranda, R. [9 ]
Becker, J. [9 ]
Li, T. [9 ]
Lin, C. [10 ]
Cornet, P. L. N. [11 ]
Schiff, M. [12 ]
机构：
[1] Univ Quebec, Ctr Hosp, Ste Foy, PQ G1V 2M3, Canada
[2] Univ Alberta, Edmonton, AB, Canada
[3] Hop Cochin, F-75674 Paris, France
[4] Pontificia Univ Catolica, Sch Med, Porto Alegre, RS, Brazil
[5] Hlth Res Oklahoma, Oklahoma City, OK USA
[6] Ctr Med Privade Reumatol, San Miguel De Tucuman, Argentina
[7] St Augustines Med Ctr, Durban, South Africa
[8] Ctr Investigac Noroeste, Tijuana, Mexico
[9] Bristol Myers Squibb Co, Princeton, NJ USA
[10] Bristol Myers Squibb Co, Hopewell Jct, NY USA
[11] Bristol Myers Squibb Co, Shanghai, Peoples R China
[12] Denver Arthritis Clin, Denver, CO USA
来源：
JOURNAL OF RHEUMATOLOGY | 2008年 / 35卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1178 / 1179
页数：2
相关论文
共 50 条
  • [41] EFFICACY AND SAFETY OF LEVILIMAB IN COMBINATION WITH METHOTREXATE IN SUBJECTS WITH ACTIVE RHEUMATOID ARTHRITIS: PHASE III, DOUBLE-BLIND, PLACEBO-CONTROLLED, RANDOMIZED TRIAL
    Mazurov, V.
    Korolev, M.
    Kundzer, A.
    Soroka, N.
    Kastanayan, A.
    Povarova, T.
    Plaksina, T.
    Antipova, O.
    Kretchikova, D.
    Smakotina, S.
    Tciupa, O.
    Raskina, T.
    Kropotina, T.
    Nesmeyanova, O.
    Popova, T.
    Dokukina, E.
    Plotnikova, A.
    Lutskii, A.
    Zinkina-Orihan, A.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 550 - 551
  • [42] Methotrexate in Crohn's disease: Results of a randomized, double-blind, placebo-controlled trial
    Arora, S
    Katkov, W
    Cooley, J
    Kemp, JA
    Johnston, DE
    Schapiro, RH
    Podolsky, D
    HEPATO-GASTROENTEROLOGY, 1999, 46 (27) : 1724 - 1729
  • [43] The probable rheumatoid arthritis: Methotrexate versus placebo treatment (the prompt) study: A double-blind randomized controlled trial
    van Dongen, H.
    van Aken, J.
    Lard, L. R.
    Visser, K.
    Ronday, H. K.
    Hulsmans, H. M. J.
    Speyer, I.
    Westedt, M. L.
    Peeters, A. J.
    Allaart, C. F.
    Toes, R. E. M.
    Breedveld, F. C.
    Huizinga, T. W. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : A33 - A33
  • [44] Filtration leukocytapepheresis therapy in rheumatoid arthritis - A randomized, double-blind, placebo-controlled trial
    Hidaka, T
    Suzuki, K
    Matsuki, Y
    Takamizawa-Matsumoto, M
    Kataharada, K
    Ishizuka, T
    Kawakami, M
    Nakamura, H
    ARTHRITIS AND RHEUMATISM, 1999, 42 (03): : 431 - 437
  • [45] TREATMENT OF RHEUMATOID-ARTHRITIS WITH L-HISTIDINE - RANDOMIZED, PLACEBO-CONTROLLED, DOUBLE-BLIND TRIAL
    PINALS, RS
    HARRIS, ED
    BURNETT, JB
    GERBER, DA
    JOURNAL OF RHEUMATOLOGY, 1977, 4 (04) : 414 - 419
  • [46] Efficacy and Safety of Ketoprofen Patch in Patients With Rheumatoid Arthritis: A Randomized, Double-Blind, Placebo-Controlled Study
    Kawai, Shinichi
    Uchida, Eiji
    Kondo, Masakazu
    Ohno, Syuji
    Obata, Junichi
    Nawata, Yasushi
    Sugimoto, Kazunori
    Oribe, Motohiro
    Nagaya, Ikuo
    JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (10): : 1171 - 1179
  • [47] Correction to: Sarilumab plus methotrexate in patients with active rheumatoid arthritis and inadequate response to methotrexate: results of a randomized, placebo-controlled phase III trial in Japan
    Yoshiya Tanaka
    Kazuteru Wada
    Yoshinori Takahashi
    Owen Hagino
    Hubert van Hoogstraten
    Neil M. H. Graham
    Hideto Kameda
    Arthritis Research & Therapy, 21
  • [48] Randomized, double-blind, placebo-controlled trial of infliximab in patients with chronic pulmonary sarcoidosis
    Baughman, RP
    Judson, MA
    Costabel, U
    duBois, RM
    Drent, M
    Kavuru, M
    Lo, KH
    Andresen, C
    Schlenker-Herceg, R
    Barnathan, ES
    CHEST, 2005, 128 (04) : 202S - 202S
  • [49] Tocilizumab Inhibits Structural Joint Damage in Rheumatoid Arthritis Patients With Inadequate Responses to Methotrexate Results From the Double-Blind Treatment Phase of a Randomized Placebo-Controlled Trial of Tocilizumab Safety and Prevention of Structural Joint Damage at One Year
    Kremer, Joel M.
    Blanco, Ricardo
    Brzosko, Marek
    Burgos-Vargas, Ruben
    Halland, Anne-Marie
    Vernon, Emma
    Ambs, Petra
    Fleischmann, Roy
    ARTHRITIS AND RHEUMATISM, 2011, 63 (03): : 609 - 621
  • [50] A Phase IIb, Randomized, Double-blind Study in Patients with Rheumatoid Arthritis Evaluating the Safety and Efficacy of Evobrutinib Compared with Placebo in Patients with an Inadequate Response to Methotrexate
    Peterfy, Charles
    Buch, Maya
    Choy, Ernest
    Schett, Georg
    Parsons-Rich, Dana
    Patel, Anand
    Zima, Yulia
    Le Bolay, Claire
    Genovese, Mark
    ARTHRITIS & RHEUMATOLOGY, 2020, 72
12345